GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Ajooni Biotech Ltd (NSE:AJOONI) » Definitions » EBIT

Ajooni Biotech (NSE:AJOONI) EBIT : ₹35.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ajooni Biotech EBIT?

Ajooni Biotech's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ₹16.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹35.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ajooni Biotech's annualized ROC % for the quarter that ended in Mar. 2024 was 8.37%. Ajooni Biotech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 17.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ajooni Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 4.55%.


Ajooni Biotech EBIT Historical Data

The historical data trend for Ajooni Biotech's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajooni Biotech EBIT Chart

Ajooni Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.96 9.98 20.00 20.45 35.45

Ajooni Biotech Quarterly Data
Mar18 Sep18 Mar19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.57 5.28 7.13 7.04 16.01

Competitive Comparison of Ajooni Biotech's EBIT

For the Packaged Foods subindustry, Ajooni Biotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajooni Biotech's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Ajooni Biotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ajooni Biotech's EV-to-EBIT falls into.



Ajooni Biotech EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹35.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ajooni Biotech  (NSE:AJOONI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ajooni Biotech's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=60.204 * ( 1 - 38.94% )/( (432.694 + 445.84)/ 2 )
=36.7605624/439.267
=8.37 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=586.704 - 140.425 - ( 13.585 - max(0, 153.832 - 419.15+13.585))
=432.694

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Ajooni Biotech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=64.02/( ( (66.646 + max(225.623, 0)) + (127.441 + max(293.135, 0)) )/ 2 )
=64.02/( ( 292.269 + 420.576 )/ 2 )
=64.02/356.4225
=17.96 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(237.162 + 113.951 + 17.825) - (140.425 + 0 + 2.89)
=225.623

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(129.59 + 153.673 + 35.12) - (25.06 + 0 + 0.188)
=293.135

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ajooni Biotech's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=35.448/778.558
=4.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ajooni Biotech EBIT Related Terms

Thank you for viewing the detailed overview of Ajooni Biotech's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajooni Biotech Business Description

Traded in Other Exchanges
N/A
Address
D-118, Industrial Area, Phase VII, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increase livestock yields. The company's products of cattle feed include Nurture Calf Starter, Winner 10ltr, Hiffer/Grower, Energy Plus, Eco- 5ltr, Milk Booster, & Buff Power, and its feed supplements include Autovita, Livtus, Caltus, Rumitus, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.

Ajooni Biotech Headlines

No Headlines